Eyerising International

Regulatory Approval

Approved in 40+ countries across Europe, the Middle East, Asia-Pacific, and Latin America.

Quality & Certifications

The Eyerising Myopia Management Device is registered in more than 40 markets worldwide and is manufactured under an ISO 13485:2016 certified quality management system. Regulatory approvals confirm the device's compliance with international quality and safety standards.

The Eyerising Myopia Management Device has been approved for use by health authorities in more than 40 countries across Europe, the Middle East, Asia-Pacific, and Latin America. Each approval means the device has successfully met the safety, quality, and performance standards set by local medical regulators.

ISO 13485:2016 Certified

Full compliance with ISO 13485:2016 - the international standard for quality management systems specific to medical device design, manufacture, and distribution. Certification demonstrates a commitment to consistent product safety and quality.

Class IIa Medical Device

Classified as a Class IIa medical device in most markets, reflecting the device's low-to-moderate risk profile. This classification requires conformity assessment by a notified body prior to market authorisation.

ARTG 412752 (Australia)

Listed on the Australian Register of Therapeutic Goods under ARTG entry 412752. Approved by the Therapeutic Goods Administration (TGA) for the management of myopia progression in children and adolescents.

Global Approvals

The Eyerising device has received regulatory approval in over 40 countries across four regions. Approvals are obtained through the relevant national regulatory authority in each market.

Europe
  • European Union
  • United Kingdom
  • Turkey
Middle East
  • United Arab Emirates
  • Saudi Arabia
Asia-Pacific
  • Australia
  • New Zealand
  • Malaysia
  • Vietnam
  • Hong Kong
Latin America
  • Colombia
  • Ecuador

Regulatory Bodies

Eyerising International has obtained approval from the following national regulatory authorities.

CE

CE Marking

European Union

MHRA

Medicines and Healthcare products Regulatory Agency

United Kingdom

TITCK

Turkish Medicines and Medical Devices Agency

Turkey

MOHAP

Ministry of Health and Prevention

United Arab Emirates

SFDA

Saudi Food and Drug Authority

Saudi Arabia

TGA

Therapeutic Goods Administration

Australia

MS

Medsafe

New Zealand

MDA

Medical Device Authority

Malaysia

DAV

Drug Administration of Vietnam

Vietnam

MDD

Medical Device Division, Department of Health

Hong Kong

INVIMA

National Food and Drug Surveillance Institute

Colombia

ARCSA

National Agency for Health Regulation, Control and Surveillance

Ecuador

Regulatory Enquiries

For questions about regulatory status in a specific market, or to request documentation for distribution or clinical use, please contact our regulatory affairs team.